Vice President, US Buyout - Healthcare

Global Private Equity Overview:

For nearly 40 years, we have harnessed our global platform to transform businesses around the world. We utilize our full platform in all stages of the investment process including sourcing, diligence and value creation. By partnering with us, our companies are able to tap into our global network to access a broad range of resources to support operational improvements, revenue growth and geographic expansion. Our diverse and global platform has also helped us to bring new and exciting opportunities to our investors and generate stable, persistent returns over the course of history. The Carlyle Global Private Equity team currently has $161bn of assets under management and over 290 portfolio companies.

Healthcare Team Overview:

The Healthcare team has deployed $16Bn+ in 25+ transactions across a range of deal sizes and transaction types, from growth minority investments to large-cap buyouts. The dedicated healthcare team invests across all verticals, including outsourced services & solutions, innovative & low-cost providers, HCIT & tech-enabled services, medical technology & products, life science tools and diagnostics, and pharma products. The team seeks investments that are "part of the solution," targeting companies that reduce costs, improve quality of care, and increase access to healthcare. Example investments include PPD (take-private and recapitalization), One Medical (growth minority), TriNetX (growth buyout), and Medline (large-cap buyout and recent IPO filing). The Vice President will join a group that has represented over a quarter of deployed CP VIII capital and generated a leading track record in the industry.

Position Summary:

As a Vice President in Carlyle's Healthcare team within the U.S. Buyout platform, you will play a pivotal role in identifying, evaluating, and executing equity investment opportunities across the healthcare landscape. This Vice President will work in close partnership with senior leaders and cross-functional colleagues to shape investment theses, structure complex transactions, and support portfolio companies in driving operational value. This position is based in New York and requires a high level of autonomy, leadership, and financial rigor, balanced by collaborative instincts and an interest in mentoring junior professionals.

This role will leverage AI technologies to streamline operations, enhance decision-making, and drive execution of key responsibilities with greater efficiency and impact. While AI is a powerful enabler, it does not replace strategic thinking; human insight and judgment will remain essential.* Lead the end-to-end evaluation and execution of leveraged buyout and growth equity transactions in the Healthcare sector, including deal structuring, diligence, and documentation.

• Oversee and mentor Associates and Senior Associates in preparing valuation models, transaction materials, and strategic analyses.
• Manage comprehensive diligence workstreams and coordinate with third-party advisors, legal counsel, and internal stakeholders.
• Present investment theses, diligence findings, and recommendations to the Investment Committee in a concise and compelling format.
• Lead negotiations of key transaction documents including stock purchase agreements, management equity terms, and financing agreements.
• Support development of operational value creation plans, including performance improvement, cost optimization, and growth initiatives.
• Collaborate with portfolio company management teams to evaluate M&A pipeline opportunities, develop inorganic growth strategies, and execute strategic add-ons.
• Monitor portfolio company performance, oversee regular reporting, and partner with management on strategic planning and board materials.
• Support firm-wide initiatives, knowledge sharing, and investment team processes with a mindset for continuous improvement.

Many of the responsibilities may be supported through the use of AI technologies, allowing greater focus on the following strategic areas:

• Identifying and developing new investment theses across evolving healthcare sub-sectors.
• Cultivating strategic relationships with industry executives, advisors, and potential deal sources.
• Driving differentiated value creation initiatives post-close that go beyond traditional levers.
• Deepening insight into regulatory and macroeconomic trends shaping the future of healthcare.

Education & Certificates

• MBA from a top-tier academic institution preferred, ideally with a concentration in finance, strategy, or economics.
• Demonstrated academic excellence and intellectual curiosity.

Professional Experience

• 3 to 6 years of progressive experience in private equity or investment banking, with at least 2 to 3 years directly supporting private equity transactions.
• Proven ability to collaboratively lead deals from sourcing through execution and portfolio management.
• Expertise in financial modeling, capital structuring, valuation techniques, and investment diligence.
• Experience interacting with and presenting to Investment Committees or equivalent governance bodies.
• Familiarity with Healthcare sector, preferred.
• Demonstrated ability to work collaboratively across functional teams, influence senior stakeholders, and operate in fast-paced, unstructured environments.
• Familiarity with applying AI technologies to accelerate investment research, market benchmarking, and deal screening.

About Us:

The Carlyle Group (NASDAQ: CG) is a global investment firm with $475 billion of assets under management, across 678 investment vehicles as of March 31, 2026. Founded in 1987 in Washington, DC, Carlyle has grown into one of the world's largest and most successful investment firms, with more than 2,500 professionals operating in 28 offices in North America, Europe, the Middle East, Asia and Australia.

Carlyle's purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors, which range from public and private pension funds to wealthy individuals and families to sovereign wealth funds, unions and corporations. Carlyle invests across three segments - Global Private Equity, Global Credit and Carlyle AlpInvest - and has deep expertise across industries, markets, and geographies.

At Carlyle, we believe that a wide spectrum of experiences and viewpoints drives performance and success. Our CEO, Harvey Schwartz, has stated that, "To build better businesses and create value for all of our stakeholders, we are focused on assembling leadership teams with the strongest insights from a range of perspectives." Reflecting this view, emphasis is placed on development, retention and inclusion through our internal processes and seven Employee Resource Groups (ERGs). We cultivate a culture where ideas are openly shared and challenged, connecting diverse expertise and perspectives to drive enduring value.